(Q39472618)

12 September 2017

Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect? (English)

1 reference

12 September 2017

0 references

0 references

0 references

V S Hubbard

1

1 reference

12 September 2017

G D Dunn

series ordinal

2

1 reference

12 September 2017

P A di Sant'Agnese

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 December 1977

1 reference

12 September 2017

1 reference

12 September 2017

2

1 reference

12 September 2017

8052-8053

1 reference

12 September 2017

1302-1304

1 reference

Vitamin A, vitamin E, and lipids in serum of children with cystic fibrosis or congenital heart defects compared with normal children

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

The effect of medium chain triglyceride upon fat absorption and plasma lipid and depot fat of children with cystic fibrosis of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Polyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Plasma Fatty Acids in Pancreatic Cystic Fibrosis and Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Unusual clinical course in a child with cystic fibrosis treated with fat emulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Defective essential-fatty-acid metabolism in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Essential fatty acids in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Enrichment of rat tissue lipids with fatty acids that are prostaglandin precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Letter: Essential fatty acid deficiency due to artificial diet in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Letter: Fatty-acid oxidation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Letter: Essential fatty acids and cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Letter: Essential-fatty-acid metabolism in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Letter: Essential-fatty-acid metabolism in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Plasma Lipids in Human Linoleic Acid Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Diagnosis and treatment of essential fatty acid deficiency in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Linoleic Acid in Serum of Patients with an Acute Serious Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

Essential fatty acids reinvestigated

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

A new prognostic score and clinical evaluation system for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2990359-2

7 January 2021

10.1016/S0140-6736(77)90359-2

Identifiers

DOI

1 reference

12 September 2017

1 reference